Department of Chemistry of Natural Compounds, University of Chemistry and Technology, Prague, Czech Republic.
Department of Immunobiology, Yale University School of Medicine, New Haven, CT, USA.
Nat Med. 2022 May;28(5):911-923. doi: 10.1038/s41591-022-01810-6. Epub 2022 May 18.
SARS-CoV-2 is not unique in its ability to cause post-acute sequelae; certain acute infections have long been associated with an unexplained chronic disability in a minority of patients. These post-acute infection syndromes (PAISs) represent a substantial healthcare burden, but there is a lack of understanding of the underlying mechanisms, representing a significant blind spot in the field of medicine. The relatively similar symptom profiles of individual PAISs, irrespective of the infectious agent, as well as the overlap of clinical features with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), suggest the potential involvement of a common etiopathogenesis. In this Review, we summarize what is known about unexplained PAISs, provide context for post-acute sequelae of SARS-CoV-2 infection (PASC), and delineate the need for basic biomedical research into the underlying mechanisms behind this group of enigmatic chronic illnesses.
SARS-CoV-2 并非唯一具有导致急性后遗留疾病能力的病毒;某些急性感染长期以来与少数患者的不明原因慢性残疾相关。这些急性后感染综合征(PAISs)代表着巨大的医疗保健负担,但对潜在机制的了解不足,这是医学领域的一个重大盲点。个体 PAISs 的相对相似的症状谱,无论病原体如何,以及与肌痛性脑脊髓炎/慢性疲劳综合征(ME/CFS)的临床特征重叠,表明潜在的共同发病机制的参与。在这篇综述中,我们总结了目前对不明原因的 PAISs 的了解,为 SARS-CoV-2 感染的急性后遗留疾病(PASC)提供了背景,并阐述了对这组神秘的慢性疾病背后的潜在机制进行基础生物医学研究的必要性。